DK0973801T3 - GnRH-antagonister - Google Patents

GnRH-antagonister

Info

Publication number
DK0973801T3
DK0973801T3 DK98918206T DK98918206T DK0973801T3 DK 0973801 T3 DK0973801 T3 DK 0973801T3 DK 98918206 T DK98918206 T DK 98918206T DK 98918206 T DK98918206 T DK 98918206T DK 0973801 T3 DK0973801 T3 DK 0973801T3
Authority
DK
Denmark
Prior art keywords
4aph
acetyl
4cpa
2nal
xaa3
Prior art date
Application number
DK98918206T
Other languages
English (en)
Inventor
Guangcheng Jiang
Graeme Semple
Jean E F Dr Rivier
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK0973801T3 publication Critical patent/DK0973801T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK98918206T 1997-04-11 1998-04-13 GnRH-antagonister DK0973801T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/837,041 US5821230A (en) 1997-04-11 1997-04-11 GnRH antagonist decapeptides
PCT/US1998/007519 WO1998046635A1 (en) 1997-04-11 1998-04-13 GnRH ANTAGONISTS

Publications (1)

Publication Number Publication Date
DK0973801T3 true DK0973801T3 (da) 2003-04-07

Family

ID=25273348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918206T DK0973801T3 (da) 1997-04-11 1998-04-13 GnRH-antagonister

Country Status (10)

Country Link
US (1) US5821230A (da)
EP (1) EP0973801B1 (da)
JP (1) JP4191259B2 (da)
AT (1) ATE229976T1 (da)
AU (1) AU7117498A (da)
DE (1) DE69810283T2 (da)
DK (1) DK0973801T3 (da)
ES (1) ES2187958T3 (da)
PT (1) PT973801E (da)
WO (1) WO1998046635A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
US5977302A (en) * 1997-11-20 1999-11-02 Ortho-Mcneil Pharmaceutical, Inc. Liquid phase process for the preparation of GnRH peptides
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) * 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
JP4524823B2 (ja) * 1999-04-14 2010-08-18 住友化学株式会社 タンパク質のアミノ末端のアミノ酸配列決定方法
US7109171B2 (en) * 2000-02-28 2006-09-19 Praecis Pharmaceuticals Inc. Methods for treating FSH related conditions with GnRH antagonists
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
US7704977B2 (en) * 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
JOP20090061B1 (ar) 2008-02-11 2021-08-17 Ferring Int Center Sa طريقة معالجة سرطان البروستاتا بمضادات الهرمونات التناسلية GnRH
WO2009137078A1 (en) * 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
EP2712622B1 (en) 2008-05-21 2016-07-13 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates
EP2424503B1 (en) 2009-05-01 2017-07-05 Ferring BV Composition for the treatment of prostate cancer
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) * 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
ES2617336T3 (es) 2010-10-27 2017-06-16 Ferring B.V. Procedimiento para la fabricación de degarelix y sus productos intermedios
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
MY182320A (en) 2012-06-01 2021-01-19 Ferring Bv Downstream process
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US5073624A (en) * 1985-04-09 1991-12-17 Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
IL101074A (en) * 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
EP0593491B1 (en) * 1991-04-25 1996-10-23 DEGHENGHI, Romano Luteinizing hormone releasing hormone antagonist peptides
US5508383A (en) * 1994-03-09 1996-04-16 Tap Holdings Inc. Cyclic peptide LHRH antagonists
US5506207A (en) * 1994-03-18 1996-04-09 The Salk Institute For Biological Studies GNRH antagonists XIII
US5681928A (en) * 1994-12-16 1997-10-28 The Salk Institute For Biological Studies Betides and methods for screening peptides using same
AU4974596A (en) * 1995-12-15 1997-07-14 Salk Institute For Biological Studies, The Betide-substituted gnrh antagonists

Also Published As

Publication number Publication date
US5821230A (en) 1998-10-13
DE69810283D1 (de) 2003-01-30
ES2187958T3 (es) 2003-06-16
PT973801E (pt) 2003-04-30
AU7117498A (en) 1998-11-11
JP4191259B2 (ja) 2008-12-03
EP0973801A1 (en) 2000-01-26
EP0973801B1 (en) 2002-12-18
ATE229976T1 (de) 2003-01-15
JP2001523232A (ja) 2001-11-20
WO1998046635A1 (en) 1998-10-22
DE69810283T2 (de) 2003-07-24

Similar Documents

Publication Publication Date Title
DE69810283D1 (de) GnRH ANTAGONISTEN
US5003011A (en) Therapeutic decapeptides
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
NO982731L (no) Antagonister av gonadotropinfrigivende hormon
EE9800173A (et) Gonadotropiini riliisinghormooni antagonistid
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
MY139203A (en) Pharmaceutical composition
KR970701730A (ko) GnRH 길항물질(GNRH ANTAGONISTS)
CA2286190A1 (en) Gnrh antagonists being modified in positions 5 and 6
SE9604341D0 (sv) Hepta-peptide oxytocin analogue
KR920004418A (ko) 브래디키닌 길항제
ATE202708T1 (de) Peptidantagonisten des bradykinin
US5413990A (en) N-terminus modified analogs of LHRH
US5502035A (en) N-terminus modified analogs of LHRH
CY1107990T1 (el) Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων
HU218288B (en) Bombesin-antagonistic polypeptide derivatives and pharmaceutical compositions containing them
DK1309613T3 (da) Farmaceutisk præparat omfattende et analgetisk peptid
KR20000076211A (ko) 택산과 조합된 돌라스태틴-15 유도체
RU2010130763A (ru) Способы и фармакологические композиции для заживления ран
KR920002628A (ko) 펩티드
EP0738154A1 (en) N-terminus modified analogs of lhrh
IE51068B1 (en) Lrf antagonists
Wasiak et al. A new category of ovulation inhibitors linear LH-RH analogues having more than ten residues
PT1363656E (pt) Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso